github link
Accession IconSRP027535

Targeting H3K4 methylation as a therapeutic strategy for Huntington''s disease (RNA-seq)

Organism Icon Mus musculus
Sample Icon 24 Downloadable Samples
Technology Badge IconIllumina Genome Analyzer IIx, Illumina HiSeq 2000

Submitter Supplied Information

Description
Transcriptional dysregulation is an early feature of Huntington''s disease (HD). We observed gene-specific changes in H3K4me3 at transcriptionally repressed promoters in R6/2 mouse and human HD brain. Genome-wide analysis showed a novel chromatin signature for this mark. Reducing the levels of the H3K4 demethylase SMCX/Jarid1c in primary neurons reversed down-regulation of key neuronal genes caused by mutant Huntingtin (Htt) expression. Finally, reduction of SMCX/Jarid1c in primary neurons from BACHD mice or the single Jarid1 in a Drosophila HD model was protective. Therefore, targeting this epigenetic signature may be an effective strategy to ameliorate the consequences of HD. Overall design: mRNA-seq in wild type and R6/2 cortex and striatum at 8 and 12 weeks.
PubMed ID
Total Samples
24
Submitter’s Institution
No associated institution

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Age
Specimen part
Subject
Processing Information
Additional Metadata
No rows found
Loading...